Advisor Process Analytical Technologies for Biologics Lilly Medicine Foundry

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life‑changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world. Organization and Position Overview Lilly recently announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. The first‑ever facility of its kind, combining research and manufacturing in a single location, the Medicine Foundry will allow Lilly to further develop innovative solutions to optimize manufacturing processes and increase capacity for clinical trial medicines, while also reducing costs and environmental impact. In the Project Delivery Phase and Startup Phase of the project (2025 to 2028), roles will be fluid and dynamic as we endeavor to support the project delivery, build a new organization, develop and implement the necessary systems and business processes required to support GMP operations. This will require significant collaboration, creativity and resilience as the Lilly Medicine Foundry goes from design, to start‑up, and to steady‑state operations. The Process Analytical Technology Advisor role, a technical‑track position, seeks a collaborative, inclusive, and energetic Process Analytical Technology (PAT) scientist who will lead the PAT strategies to be utilized at the Lilly Medicine Foundry to support the production of biologic drug substance processes. This role will collaborate with the parent CMC development organizations to understand the needs of the portfolio and PAT to be implemented in production. The Lilly Medicine Foundry, a state‑of‑the‑art facility, will utilize the latest in automation to further the analytical capabilities including on‑line in‑process control testing through material release and on‑going process monitoring at the site. The PAT group will consist of high‑level scientists focused on the implementation of new technologies and analytical process improvements. This position involves working cross‑functionally within the site and across the network to develop strategic functional capabilities and will ensure appropriate capacity, capabilities and business processes are developed, implemented and sustained to deliver the required information to the project teams. This position will be key to ensuring a strong safety culture and establishing a safety, quality and continuous improvement focused mindset within the organization. Responsibilities Drive implementation of technical solutions and analytical strategies via PAT to enable biologic drug substance production at the Lilly Medicine Foundry. Provide technical leadership for the adoption and use of PAT (e.g., Raman, UV, capacitance) in upstream and downstream biological processes to be executed at the Lilly Medicine Foundry. Investigate the feasibility of instruments to use for in‑line monitoring. Ensure methods are technically sound, well developed, and fit‑for‑purpose. Demonstrate high learning agility and the ability to understand and exploit effective scientific concepts and methods across multiple subject areas (e.g., biochemistry, PAT, and modeling and simulation). Support automation development (i.e., integrated control systems) between PAT tools and process data systems (i.e., synTQ or other systems). Mentor and develop scientific staff. Ensure continued technical and professional growth of group members, encourage efforts towards excellence and knowledge sharing. Plan and manage short‑term and long‑term development activities. Develop and/or review technical agendas and timelines for project work. Recommend resource allocation to accomplish projects according to plans, communicate progress and propose changes in timeline, objectives, or direction. Collaborate closely with organizations across development and manufacturing to deliver material and information for clinical trials and regulatory submissions. Welcome varied perspectives to create new solutions. Coordinate instrumentations between different projects to allow equal usage of available tools for project specific needs. Author or contribute to technical documents including SOPs, technology transfer documents, process flow diagrams, regulatory submissions, patents, and scientific papers. Ensure work and team activities are aligned with all relevant development quality, regulatory, HSE, GLP and GMP requirements. Basic Requirements Ph.D. in biochemistry, chemical engineering, biochemical engineering or related STEM field; M.S. with 10+ years of experience. A background in process analytics with a strong focus on bioprocess analytics, including spectroscopic methods, chromatographic techniques, and/or cell culture monitoring. Demonstrated expertise leading analytical efforts in pharmaceutical product development and commercialization. Proven skills developing, validating, and transferring analytical methods. Fundamental knowledge of cGMP compliance requirements and cGMP experience. Additional Preferences Experience with product development, including technical transfer of analytical methods into manufacturing operations. Demonstrated ability to drive and accept change. Good interpersonal skills and a sustained tendency for collaboration. Demonstrated success in persuasion, influence, and negotiation. Ability to prioritize multiple activities and manage ambiguity. Must possess strong communication (oral, written), organizational, and leadership skills. Other Information Initial location at Lilly Technology Center, Indianapolis or Parkwood West, Indianapolis. Permanent location at the new Lilly Medicine Foundry in Lebanon, Indiana. Flexibility to work from Indianapolis (or other Lilly sites) may be required throughout 2026 and 2027. Position requires on‑site presence, 8‑hour days, five days per week, with flexibility to support activities during shutdowns, weekends, etc. 0‑10% travel required. Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response. Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status. Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is $126,000 - $204,600. Full‑time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company‑sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well‑being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities). Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees. #J-18808-Ljbffr Initial Therapeutics, Inc.